Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
ABSTRACT Context Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS), yet the androgen(s) responsible remain ambiguous. Recent studies have suggested that 11‐oxygenated C19 steroids (11‐oxyandrogens), specifically 11‐ketotestosterone, may be a good marker for hyperandrogenism in PCOS....
Saved in:
Main Authors: | Armaiti Parvez Mody, Maya Beth Lodish, Richard Joseph Auchus, Adina F. Turcu, Fei Jiang, Heather Gibson Huddleston |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Endocrinology, Diabetes & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1002/edm2.70022 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01) -
Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01) -
The role of CLDN11 in promotion of granulosa cell proliferation in polycystic ovary syndrome via activation of the PI3K-AKT signalling pathway
by: Min Wang, et al.
Published: (2025-01-01) -
Does Baseline Serum Androgen Levels Have an Impact on Ovulation Induction Cycle Outcomes by Using Clomifene Citrate among Infertile Women with Polycystic Ovary Syndrome? A Retrospective Cohort Study
by: Serkan Kahyaoglu, et al.
Published: (2023-08-01) -
Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)